Femara (Letrozole) – Patient Guide (Australia)

Femara is the brand name of letrozole, an anti-cancer medicine used primarily for certain types of hormone-sensitive breast cancer in post-menopausal women. This guide explains what Femara is, how it works, how it is taken, what to expect, and important safety and interaction information. It is written for general patient education and should be read alongside advice from your healthcare professional.

Key information at a glance

• Medicine: Femara (letrozole)
• What it does: Lowers oestrogen levels by blocking an enzyme called aromatase.
• Common use: Hormone receptor–positive breast cancer (often after surgery or as part of long-term treatment).
• Who it’s for: Typically used in post-menopausal patients (and in some cases based on specific clinical situations).
• How it’s taken: Usually once daily by mouth.
• Important considerations: Bone health, monitoring of side effects, and interactions with other medicines.

Basic product information

Femara (letrozole) is supplied as oral tablets. Letrozole belongs to a class of medicines called aromatase inhibitors. In Australia, availability is subject to prescribing practices and Pharmaceutical Benefits Scheme (PBS) criteria where applicable.

Strengths: Tablets are commonly available in 2.5 mg strength (other strengths may not be marketed widely in Australia).

How it comes to you: Depending on your local pharmacy arrangement, tablets are dispensed in blister packs or pharmacy packaging. Always check the pack for the correct strength and expiry date.

How Femara works (mechanism of action)

Many breast cancers are “hormone receptor–positive,” meaning they rely on oestrogen to grow or survive. In post-menopausal women, oestrogen is produced largely in peripheral tissues (such as fat and muscle) by converting androgens to oestrogens.

Letrozole reduces oestrogen production by inhibiting the enzyme aromatase. Lower oestrogen levels can help slow the progression of hormone-sensitive cancer and reduce the risk of recurrence in certain settings.

• Aromatase inhibition: Blocks conversion of androgens → oestrogens.
• Oestrogen lowering: Helps “starve” oestrogen-dependent cancer cells.
• Not a chemotherapy drug: Its effect is hormone-directed.

Pharmacokinetics (how the body handles Femara)

Pharmacokinetics describe how the medicine is absorbed, distributed, metabolised, and eliminated. Understanding these features helps explain onset and duration of effect, and why certain interactions may matter.

• Absorption: Letrozole is absorbed after oral dosing.
• Peak levels: Blood concentrations typically reach peak levels within a few hours after a dose.
• Metabolism: Letrozole is metabolised primarily in the liver.
• Elimination: Metabolites are cleared via the body’s normal excretory pathways.
• Steady state: With daily dosing, drug levels build to steady concentrations over time.

Clinically, the most important takeaway is that Femara is designed for once-daily oral use and achieves a sustained reduction in aromatase activity.

Typical indications (what Femara is used for)

Femara is indicated for hormone receptor–positive breast cancer, particularly in post-menopausal patients. Indications can differ by individual clinical circumstances and treatment history.

Common clinical uses include:

• Early breast cancer: Adjuvant treatment to reduce the risk of recurrence (often after surgery and/or other therapies).
• Advanced or metastatic breast cancer: Treatment when the cancer has spread or progressed, typically in hormone receptor–positive settings.
• Oestrogen deprivation strategy: Used as part of long-term hormonal control.

Your specialist will determine the most appropriate treatment plan and duration based on tumour biology, staging, prior therapies, and menopausal status.

Dosing and timing

The dose of Femara is commonly 2.5 mg by mouth once daily. Your healthcare professional will confirm the correct dose and schedule for you.

How to take Femara

• Once daily: Take at the same time each day when possible.
• With or without food: Food does not usually prevent use, though interactions with certain supplements and medicines should be considered.
• Swallow whole: Swallow the tablet with water. Do not crush or chew unless instructed.
• If you miss a dose:
  • Take it as soon as you remember on the same day.
  • If it is close to the time of your next dose, skip the missed dose and continue with the regular schedule.
  • Do not double up to make up for a missed tablet.

How long is treatment?

Treatment length varies. Some patients take Femara for years as part of adjuvant therapy to reduce recurrence risk. Do not stop early without medical advice, even if you feel well.

Food interactions

Letrozole can generally be taken with or without food. There is no standard requirement to take it on an empty stomach.

However, consider the following:

• Hormone-containing products: Avoid supplements or medicines that contain oestrogen or hormones unless your doctor specifically advises otherwise.
• Herbal products: Some herbal supplements may influence hormone pathways or liver enzymes. Examples include products containing phytoestrogens (e.g., red clover preparations). Discuss any supplements before use.
• Grapefruit and certain fruit: Grapefruit can affect liver enzymes involved in drug metabolism in some medicines. While letrozole’s interactions are not typically described in the same way as with some other drugs, it’s wise to avoid heavy grapefruit intake without medical advice.

If you have dietary concerns or take regular supplements, ask your pharmacist to review them for potential interactions.

Alcohol and medicine interactions

Alcohol is not typically listed as a direct contraindication for letrozole. However, alcohol can worsen certain side effects such as: fatigue, hot flushes, sleep disruption, nausea, and can affect overall wellbeing.

General guidance:

• Use moderation: If you drink alcohol, consider keeping intake low and consistent.
• Watch for side effects: If you notice increased dizziness or tiredness after drinking, avoid alcohol.
• Medication interactions: The main interaction risk is often with other medicines that affect liver metabolism.

Always tell your healthcare professional about all medicines you take, including over-the-counter drugs and supplements.

Drug interactions (including common categories)

Letrozole is metabolised in the liver, meaning other medicines may influence its levels. This can affect effectiveness or side effects.

Important interaction categories to discuss with your pharmacist/doctor:

• Liver enzyme–affecting medicines: Some medicines can increase or decrease drug metabolism.
• Hormone therapies: Oestrogen-containing hormone replacement or fertility treatments are generally not compatible with the intent of an aromatase inhibitor.
• Warfarin: If you use anticoagulants, you may need closer monitoring when medicines change. Ask about blood test schedules and signs of bleeding.
• Other cancer therapies: Combination regimens should be managed by your oncology team.
• Some anti-seizure medicines: Certain agents can change liver enzyme activity.

For a safe review, keep a list of your medicines (including vitamins and herbal supplements) and share it during consultations.

Safety profile and side effects

Like all medicines, Femara can cause side effects. Many are manageable, and most patients do not experience all possible reactions. The most important safety themes include effects on the musculoskeletal system, bone density, and cardiovascular risk factors.

Common side effects

• Hot flushes
• Fatigue
• Joint pain or stiffness (arthralgia)
• Muscle aches
• Headache
• Nausea
• Reduced appetite (in some cases)
• Swelling (e.g., hands/feet) may occur

Less common but important side effects

• Bone thinning (osteoporosis) and increased fracture risk
• Cholesterol changes (lipids may be monitored)
• Skin rash or itching
• Gastrointestinal symptoms such as diarrhoea or constipation

Seek urgent medical help if you experience

• Signs of a severe allergic reaction: swelling of face/lips, trouble breathing, severe rash.
• Chest pain, sudden shortness of breath, or stroke-like symptoms.
• Severe or worsening bone pain or symptoms that could indicate a fracture.
• Unusual bleeding or bruising if you take blood thinners.

Bone health and monitoring

Aromatase inhibitors reduce oestrogen levels, which can contribute to bone thinning. Many treatment plans include bone monitoring and prevention strategies.

Typical practical steps:

• Baseline and follow-up bone density testing (DEXA scan) as advised.
• Calcium and vitamin D intake may be recommended (preferably through diet; supplements if needed).
• Exercise: weight-bearing and resistance exercises (as tolerated and appropriate for your condition).
• Medications for bone protection may be considered in some patients.

Don’t start bone supplements without checking with your clinician—especially if you have kidney problems or other medical conditions.

Practical use tips for patients

• Set a daily reminder: A consistent time helps reduce missed doses.
• Manage joint stiffness: Gentle stretching, regular movement, and low-impact exercise can help. Report persistent symptoms early—your team may suggest pain control strategies or adjustments in supportive care.
• Track side effects: Keep a simple note (e.g., hot flush frequency, pain severity) to discuss with your doctor.
• Hydration and sleep routines: These may help fatigue and hot flushes. Consider cooling measures for night sweats.
• Be cautious with supplements: Especially those containing oestrogenic ingredients.
• Attend scheduled monitoring: Bone density, cholesterol checks, and follow-up visits are important.

Alternative options

Depending on the cancer stage, tumour biology, prior treatment, and menopausal status, your healthcare team may consider alternatives to letrozole. Options can include:

• Other aromatase inhibitors: e.g., anastrozole, exemestane.
• Selective oestrogen receptor modulators (SERM): e.g., tamoxifen in appropriate settings.
• Oestrogen receptor downregulators: selected agents may be used for specific disease situations.
• Ovarian suppression: in certain pre-/perimenopausal contexts, doctors may use ovarian suppression strategies.
• Other cancer-directed treatments: chemotherapy, targeted therapy, radiation—depending on clinical need.

If side effects are difficult to manage, discuss your options promptly. Sometimes switching within the aromatase inhibitor class or adjusting supportive care can improve tolerability.

Market and legal context in Australia

In Australia, medicines are supplied and monitored under strict regulatory frameworks. Letrozole-containing products are considered medicines with defined indications and dispensing requirements. Supply is typically coordinated through pharmacy channels in line with Australian health regulations.

Important points:

• Quality and authenticity: Choose reputable, licensed supply channels to ensure correct product quality and labelling.
• Safety information: Patient information leaflets and pharmacy counselling support informed use.
• Ongoing clinical oversight: Breast cancer treatment requires coordinated care and monitoring.

Recent guidance and evolving care

Treatment recommendations for hormone receptor–positive breast cancer may evolve as new evidence emerges. Recent clinical focus areas often include:

• Managing side effects (especially musculoskeletal symptoms and bone health)
• Adherence strategies to support long-term use
• Cardiovascular and metabolic monitoring (e.g., cholesterol) where appropriate
• Individualising duration of adjuvant therapy based on risk and tolerability

Your oncology team will follow current Australian and international guidelines relevant to your diagnosis and treatment stage.

Delivery and availability (online pharmacy)

Availability of Femara (letrozole) may vary by region and stock levels. When ordering through an online pharmacy, your dispensing process is typically subject to:

• Prescription verification and patient details (where applicable)
• Stock confirmation at the time of dispensing
• Shipping timelines based on your location

What to expect:

• Packaging: Tablets are delivered in secure pharmacy packaging.
• Tracking: Many delivery services include tracking updates.
• Cold chain: Generally not required for tablets.
• Delivery timeframes: Depend on carrier and state/territory.

If you need urgent supplies, contact the pharmacy support team for guidance on dispatch options.

Storage and handling

• Store below 30°C (unless your pack specifies otherwise).
• Keep in original packaging to protect from moisture/light.
• Keep out of reach of children.
• Do not use after expiry date.

FAQ – Femara (Letrozole)

1) What is Femara used for?

Femara (letrozole) is used mainly for hormone receptor–positive breast cancer in post-menopausal patients, including early-stage adjuvant treatment and treatment of advanced disease in appropriate clinical situations.

2) How quickly will it start working?

Letrozole lowers oestrogen levels after dosing. In the context of breast cancer treatment, the overall effect is evaluated over weeks to months with ongoing monitoring and follow-up.

3) Can I take Femara with food?

Yes. Femara can usually be taken with or without food. Choose a time you can stick to daily.

4) What should I do if I miss a dose?

Take it when you remember on the same day. If it is close to the next dose, skip the missed dose and continue as normal. Do not double doses.

5) Are there tests I should have while taking Femara?

Common monitoring includes bone density (DEXA scans), blood tests such as lipids in some patients, and regular clinical follow-ups. Your doctor will tailor tests to your overall health and treatment plan.

6) Will Femara cause weight gain?

Some patients experience changes in weight, but weight change can vary. Fatigue and activity changes can influence weight. If you notice significant or rapid changes, discuss them with your clinician.

7) What helps with joint pain?

Gentle movement, stretching, physiotherapy-style exercises, heat or cool packs, and simple pain strategies can help. If joint symptoms are persistent, report them promptly—your care team can recommend targeted supportive treatment.

8) Can I take vitamin D or calcium?

Many treatment plans include calcium and vitamin D for bone support. However, it’s best to confirm the appropriate dose with your doctor or pharmacist, especially if you have kidney disease or other medical conditions.

9) Does Femara interact with my other medications?

It may interact with medicines that affect liver metabolism or those that influence hormone levels. Provide your pharmacist with a complete list of medicines and supplements to check safety.

10) Is it safe to drink alcohol?

Alcohol is not usually prohibited, but it may worsen fatigue, sleep issues, or hot flushes. Keep intake modest and stop or reduce if side effects increase.

11) What is the risk to my bones?

By lowering oestrogen, Femara may reduce bone density. This is why bone monitoring and prevention strategies (exercise, calcium/vitamin D, and sometimes bone-protective medication) are important.

When to contact your healthcare team

Contact your doctor or pharmacist if you experience bothersome side effects that affect daily activities, symptoms suggesting a fracture or severe bone pain, or any signs of an allergic reaction. If you’re unsure whether a medicine or supplement is safe with Femara, check before starting.

Disclaimer: This information is for general education only and does not replace professional medical advice. Your treatment and monitoring should be personalised to your diagnosis and health circumstances.